Skip to main content


Table 1 Categorization of cytotoxic chemotherapies received during the study period

From: Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancer

Category A Category B
5-Fluorouracil Capecitabine
Epirubicin Docetaxel
Doxorubicin Gemcitabine
Cyclophosphamide Ixabepilone
Etoposide Liposomal doxorubicin
Ifosfamide Nab-paclitaxel
Methotrexate Paclitaxel
Cisplatin Vinorelbine
  1. Novel agents were considered to be those approved since 1994 and are listed in Category B, while other available agents are included in Category A.